These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 318675)
1. Alteration of effectiveness of antibiotics by anaerobiosis. Verklin RM; Mandell GL J Lab Clin Med; 1977 Jan; 89(1):65-71. PubMed ID: 318675 [TBL] [Abstract][Full Text] [Related]
2. A multicentre study of the susceptibility of a variety of bacteria to cephalothin, cefamandole, tobramycin and gentamicin. du T Naudé W; van den Ende J; Botha P; Forder A; Hyland J; de Klerk HC; Neiteler BF; Koornhof HJ; Robinson R; Robins-Browne R; Block C; Appelbaum PC; Africa CW; van Rensburg AJ; Jooste PJ; Crewe-Browne H; Fernandez A S Afr Med J; 1977 Nov; 52(20):798-800. PubMed ID: 305120 [TBL] [Abstract][Full Text] [Related]
3. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance. Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482 [TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)]. Shah PM; Zwischenbrugger H; Stille W MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of netilmicin and cefotaxime compared to that of other aminoglycosides. Shah PM; Belve V Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):285-8. PubMed ID: 552591 [TBL] [Abstract][Full Text] [Related]
6. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy. Bovelacci A; Montini G; Ramacciotti PG Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413 [TBL] [Abstract][Full Text] [Related]
7. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin]. Schassan HH; Bentfeld G Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of four recently introduced cephalosporins with respect to probability of resistance in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. (author's transl)]. Loch R; Schröter G Zentralbl Bakteriol Orig A; 1979; 245(3):312-6. PubMed ID: 44785 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967 [TBL] [Abstract][Full Text] [Related]
10. [Profile of antimicrobial resistance of agents causing urinary tract infections in children]. Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole. Greenberg RN; Bollinger M Clin Ther; 1985; 7(2):151-3. PubMed ID: 3886140 [TBL] [Abstract][Full Text] [Related]
12. Comparison of effectiveness of aminoglycosides and cephalosporins in gram-negative rods. Vrbová E; Uxová M; Výmola F Czech Med; 1986; 9(3):148-52. PubMed ID: 3095073 [TBL] [Abstract][Full Text] [Related]
13. [Study on the antibacterial activity of penicillins and cephalosporines in urine (author's transl)]. Shah PM; Schirmer KP; Helm EB; Stille W Arzneimittelforschung; 1976; 26(9):1636-8. PubMed ID: 826261 [TBL] [Abstract][Full Text] [Related]
14. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Tan TY; Ng SY; Teo L; Koh Y; Teok CH J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Cha R Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108 [TBL] [Abstract][Full Text] [Related]